References
- Artursson P, Borchardt RT. 1997. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm Res. 14:1655–1658.
- Balkovetz DF. 2006. Claudins at the gate: determinants of renal epithelial tight junction paracellular permeability. Am J Physiol Renal Physiol. 290:572–579.
- Chediack JG, Caviedes-Vidal E, Fasulo V, Yamin LJ, Karasov WH. 2003. Intestinal passive absorption of water-soluble compounds by sparrows: effect of molecular size and luminal nutrients. J Comp Physiol B Biochem Syst Environ Physiol. 173:187–197.
- Fromter E, Diamond J. 1972. Route of passive ion permeation in epithelia. Nat New Biol. 238:9–13.
- Horio M, Chin KV, Currier SJ, Goldenberg S, Williams C, Pastan I, Gottesman MM, Handler J. 1989. Transepithelial transport of drugs by the multidrug transporter in cultured Madin–Darby canine kidney cell epithelia. J Biol Chem. 264:14880–14884.
- Jiang XH, Jia YT, Yuan Y. 2002. Application of Caco-2 cell model in the study of oral drug absorption process. Chin Pharm J. 37:325–327.
- Leppert PS, Fix JA. 1994. Use of everted intestinal rings for in vitro examination of oral absorption potential. J Pharm Sci. 83:976–81.
- Luo S, Kansara VS, Zhu X, Mandava NK, Pal D, Mitra AK. 2006. Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery. Mol Pharm. 3:329–339.
- O'Brien FE, O'Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF. 2014. The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram. Behav Brain Res. 261:17–25.
- Shen K, Wang JT. 2003. Progress in experimental methods for study of drugs’ intestinal absorption. Chin J New Drugs. 12:988–991.
- Song G, Luo Q, Qin J, Wang L, Shi Y, Sun C. 2006. Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells. Colloids Surf B Biointerfaces. 48:1–5.
- Tang L, Dong LN, Peng XJ, Li Y, Zhou FY, Liu ZQ. 2013. Pharmacokinetic characterization of oxymatrine and matrine in rats after oral administration of radix Sophorae tonkinensis extract and oxymtrine by sensitive and robust UPLC–MS/MS method. J Pharm Biomed Anal. 83:179–185.
- Tervonen A, Vainio I, Nymark S, Hyttinen J. 2014. Prediction of passive drug permeability across the blood-retinal barrier. Pharm Res. 31:2297–2311.
- Turner JR, Buschmann MM, Romero-Calvo I, Sailer A, Shen L. 2014. The role of molecular remodeling in differential regulation of tight junction permeability. Semin Cell Dev Biol. 36:204–212.
- Twentyman PR, Luscombe MA. 1987. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer. 56:279–85.
- Varma MV, Ashokraj Y, Dey CS, Panchagnula R. 2003. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res. 48:347–359.
- Wang SJ, Wang GJ, Li XT, Sun JG, Ma RL, Sheng LS. 2004. Pharmacokinetics of oxymatrine in Beagle dogs by LC–MS. Chin J Clin Pharmacol Ther. 25:585–587.
- Wang SJ, Wang GJ, Li XT, Ma RL, Sheng LS, Sun JG. 2005a. Pharmacokinetics of oxymatrine and its metabolite in beagle dogs detected by LC–MS. J Chin Mataria Med. 30:133–136.
- Wang SJ, Wang GJ, Li XT, Ma RL, Sun JG, Sheng LS. 2005b. Simultaneous determination of oxymatrine and its active metabolite matrine in dog plasma by liquid chromatography–mass spectrometry and its application to pharmacokinetic studies. J Chromatogr B. 817:319–325.
- Yang JH, Hou YH, Ji GJ, Song Z, Liu Y, Dai G, Zhang Y, Chen J. 2014. Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats. Eur J Pharm Sci. 52:180–190.
- Yuan J, Zhang ZJ, Cong B. 2003. Biological activity of matrine and its research progress. Pesticides. 42:1–4.